Sumokla, Baby Boy -.
HRN: 22-18-79 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2022
AMPICILLIN 500MG (VIAL)
11/18/2022
11/25/2022
IV
125mg
Q12
Sepsis Neonatorum
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes